# EDGAR Filing Document

**Accession Number:** 0001754195
**File Stem:** 0001213900-26-070732
**Filing Date:** 2026-6
**Character Count:** 8377
**Document Hash:** 4b3db75ee38feefb22bc93a7d31ce1c5
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001213900-26-070732.hdr.sgml**: 20260622

**ACCESSION NUMBER**: 0001213900-26-070732

**CONFORMED SUBMISSION TYPE**: 4

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20260617

**FILED AS OF DATE**: 20260622

**DATE AS OF CHANGE**: 20260622

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Rivers Kim A.
- **CENTRAL INDEX KEY:** 0001841319

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-43338
- **FILM NUMBER:** 261108297

**MAIL ADDRESS:**
- **STREET 1:** C/O TRULIEVE CANNABIS CORP.
- **STREET 2:** 3494 MARTIN HURST ROAD
- **CITY:** TALLAHASSEE
- **STATE:** FL
- **ZIP:** 32312
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Trulieve Cannabis Corp.
- **CENTRAL INDEX KEY:** 0001754195
- **STANDARD INDUSTRIAL CLASSIFICATION:** MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 581882476
- **STATE OF INCORPORATION:** A1
- **FISCAL YEAR END:** 1231

**BUSINESS ADDRESS:**
- **STREET 1:** 3494 MARTIN HURST ROAD
- **CITY:** TALLAHASSEE
- **STATE:** FL
- **ZIP:** 32312
- **BUSINESS PHONE:** 8502988866

**MAIL ADDRESS:**
- **STREET 1:** 3494 MARTIN HURST ROAD
- **CITY:** TALLAHASSEE
- **STATE:** FL
- **ZIP:** 32312

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 4

### STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

[x] Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Rivers Kim A.<br><sub>(Last) (First) (Middle)</sub><br>C/O TRULIEVE CANNABIS CORP.<br>3494 MARTIN HURST ROAD<br><sub>(Street)</sub><br>TALLAHASSEE, FL 32312<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2026-06-17 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[X] Director [X] 10% Owner<br>[X] Officer (give title below) [ ] Other (specify below)<br>_Chairman and CEO_ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>Trulieve Cannabis Corp. [ TRLV ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | 3. Transaction Code (V) | 3. Transaction Code (V) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | Code | V | Amount | (A) or (D) | Price | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| Subordinate Voting Shares | 2026-06-17 |  | S<sup>(1)</sup> |  | 137535 | D | 9.359<sup>(2)</sup> | 3038385 | D |  |
| Subordinate Voting Shares | 2026-06-18 |  | S<sup>(1)</sup> |  | 139846 | D | 9.46<sup>(3)</sup> | 2898539 | D |  |
| Subordinate Voting Shares | 2026-06-22 |  | S<sup>(1)</sup> |  | 204815 | D | 9.354<sup>(4)</sup> | 2693724<sup>(5)</sup> | D |  |

---

## Table II - Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | 4. Transaction Code (V) | 4. Transaction Code (V) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 6. Date Exercisable and Expiration Date | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Underlying Securities | 7. Title and Amount of Underlying Securities | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| Multiple Voting Shares | $0 |  |  |  |  |  |  | <sup>(6)</sup> | <sup>(6)</sup> | Subordinate Voting Shares | 15166700 |  | 151667 | D |  |
| Multiple Voting Shares | $0 |  |  |  |  |  |  | <sup>(6)</sup> | <sup>(6)</sup> | Subordinate Voting Shares | 986700 |  | 9867 | I | By Traunch IV LLC<sup>(7)</sup> |

---

### Footnotes:

(1) This transaction was effected pursuant to a Rule 10b5-1 plan to sell 2.5 million shares adopted by the reporting person on March 16, 2026. A Form 144 covering the first tranche of 1,699,007 subordinate voting shares was filed on June 17, 2026. The second tranche of remaining shares will be eligible for sale after September 15, 2026.

(2) Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $9.11 to $9.65. The reporting person has provided to the issuer, and undertakes to provide to the staff of the Commission or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range.

(3) Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $9.27 to $9.72. The reporting person has provided to the issuer, and undertakes to provide to the staff of the Commission or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range.

(4) Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $9.22 to $9.52. The reporting person has provided to the issuer, and undertakes to provide to the staff of the Commission or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range.

(5) The reporting person also holds Multiple Voting Shares convertible into Subordinate Voting Shares as reported on Table II of this Form 4.

(6) The Multiple Voting Shares are convertible into Subordinate Voting Shares on a one-for-100 basis. The Multiple Voting Shares are convertible at any time and have no expiration date.

(7) The Multiple Voting Shares are held by Traunch IV LLC ("Traunch IV"), over which the reporting person may be deemed to exercise voting and investment control. The reporting person disclaims beneficial ownership of the Multiple Voting Shares (and the Subordinate Voting Shares into which they are convertible) held by Traunch IV, except to the extent of her pecuniary interest therein.

**Signature:** /s/ Eric Powers, as Attorney-in-Fact  
**Date:** 2026-06-22

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**